MLICM
CDK

Metropolitan Life Insurance Company (MetLife)’s CDK Global, Inc. CDK Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CDK Stock Details CDK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-22,029
Closed -$919K – 2787
2021
Q4 		$919K Sell
22,029
-1,096
-5% -$46K 0.01% 1029
2021
Q3 		$984K Sell
23,125
-804
-3% -$36.2K 0.01% 967
2021
Q2 		$1.19M Buy
23,929
+92
+0.4% +$4.87K 0.02% 877
2021
Q1 		$1.29M Buy
23,837
+1,141
+5% +$59.2K 0.02% 778
2020
Q4 		$1.18M Sell
22,696
-572
-2% -$27.1K 0.02% 778
2020
Q3 		$1.01M Sell
23,268
-1,211
-5% -$53.8K 0.02% 738
2020
Q2 		$1.01M Sell
24,479
-13,434
-35% -$517K 0.02% 732
2020
Q1 		$1.25M Sell
37,913
-2,022
-5% -$96.6K 0.03% 582
2019
Q4 		$2.18M Buy
39,935
+83
+0.2% +$4.26K 0.03% 497
2019
Q3 		$1.92M Sell
39,852
-1,173
-3% -$56.2K 0.03% 522
2019
Q2 		$2.03M Sell
41,025
-1,009
-2% -$54K 0.03% 518
2019
Q1 		$2.47M Sell
42,034
-1,635
-4% -$89.1K 0.04% 376
2018
Q4 		$2.09M Sell
43,669
-116
-0.3% -$6.12K 0.04% 399
2018
Q3 		$2.74M Buy
43,785
+1,063
+2% +$67.4K 0.05% 361
2018
Q2 		$2.78M Buy
42,722
+531
+1% +$34.3K 0.05% 351
2018
Q1 		$2.67M Sell
42,191
-1,193
-3% -$83.5K 0.04% 375
2017
Q4 		$3.09M Sell
43,384
-216,906
-83% -$14.6M 0.04% 328
2017
Q3 		$16.4M Buy
260,290
+117,926
+83% +$7.43M 0.1% 170
2017
Q2 		$8.84M Buy
142,364
+694
+0.5% +$43.5K 0.06% 291
2017
Q1 		$9.21M Sell
141,670
-4,420
-3% -$283K 0.06% 283
2016
Q4 		$8.72M Sell
146,090
-1,500
-1% -$85.8K 0.06% 295
2016
Q3 		$8.47M Sell
147,590
-5,427
-4% -$312K 0.06% 291
2016
Q2 		$8.49M Buy
153,017
+4,800
+3% +$248K 0.06% 289
2016
Q1 		$6.9M Buy
148,217
+444
+0.3% +$19.8K 0.05% 351
2015
Q4 		$7.01M Buy
147,773
+361
+0.2% +$17.5K 0.05% 331
2015
Q3 		$7.04M Sell
147,412
-1,447
-1% -$73.4K 0.05% 339
2015
Q2 		$8.04M Buy
+148,859
New +$7.64M 0.06% 328
2015
Q1 		– Sell
-143,165
Closed -$5.83M – 2503
2014
Q4 		$5.83M Buy
+143,165
New +$5.07M 0.04% 455

Other funds holding CDK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.18B AUM 0.37% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CDK Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of CDK Global, Inc. (CDK) in Q1 2022, closing a stake of 22,029 shares — an estimated $919K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CDK in Q4 2014 and held it in 28 quarters. The position peaked at $16.4M in Q3 2017. 466 funds tracked by Wall St. Rank hold CDK as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining CDK Global, Inc. position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 22,029 CDK Global, Inc. shares in Q1 2022, an estimated $919K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in CDK Global, Inc. in Q4 2014 and held it in 28 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s CDK Global, Inc. position peaked at $16.4M in Q3 2017.
  • 466 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.